On improving the min test for the analysis of combination drug trials

DOI10.1080/00949659508811632zbMath0842.62090OpenAlexW2128405110MaRDI QIDQ4869577

Steve M. Snapinn, Wenjin Wang, Sanat Kumar Sarkar

Publication date: 26 March 1996

Published in: Journal of Statistical Computation and Simulation (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/00949659508811632

zbMATH Keywords

clinical trialssignificance levelsuniformly most powerfulcombination therapiesimproved testsmin tests

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (6)

Tests of a normal mean vector with hypotheses determined by linear inequalities ⋮ A general testing for order restriction on mean vectors of multivariate normal populations ⋮ On the computation of some properties of testing homogeneity of multivariate normal mean vectors against an order restriction ⋮ Parametric and permutation testing for multivariate monotonic alternatives ⋮ Upper Bound forp-Value of the Test of Multivariate Normal Ordered Mean Vectors Against all Alternatives ⋮ Construction of uniformly more powerful tests for hypotheses about linear inequalities

Cites Work

• Tests uniformly more powerful than uniformly most powerful monotone tests
• Testing Whether an Identified Treatment Is Best
• A test of a multivariate normal mean with composite hypotheses determined by linear inequalities
• Comparison of treatments in a combination therapy trial
• Uniformly More Powerful Tests for Hypotheses Concerning Linear Inequalities and Normal Means

This page was built for publication: On improving the min test for the analysis of combination drug trials